These results suggest that most breast cancer cells are responsible for HG-induced activation of the NRG1 enhancer, although NRG1 overexpression in triple negative breast cancer cells such as MDA-MB-231 and BT-20 is less affected by HG. The gene discussed is NRG1; the disease is breast carcinoma.